DPAM
WST icon

Degroof Petercam Asset Management’s West Pharmaceutical WST Stock Holding History

Degroof Petercam Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.73M Hold
11,950
– – 0.06% 221
2023
Q4 		$4.21M Buy
+11,950
New +$4.23M 0.06% 239

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Degroof Petercam Asset Management's WST Position: Q1 2024 in Review

Degroof Petercam Asset Management held its West Pharmaceutical (WST) position steady in Q1 2024 at 11,950 shares worth $4.73M. The position accounts for 0.06% of the portfolio, ranked #221.

Degroof Petercam Asset Management first reported a position in WST in Q4 2023 and has held it in 2 quarters since. 779 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Degroof Petercam Asset Management held 11,950 shares of West Pharmaceutical worth $4.73M as of Q1 2024.
  • Degroof Petercam Asset Management left its West Pharmaceutical share count unchanged in Q1 2024.
  • West Pharmaceutical made up 0.06% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #221 holding.
  • Degroof Petercam Asset Management first reported a position in West Pharmaceutical in Q4 2023 and has held it in 2 quarters since.
  • 779 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.